The price of IGC Pharma Inc (AMEX: IGC) closed at $0.40 in the last session, down -0.25% from day before closing price of $0.40. In other words, the price has decreased by -$0.0010 from its previous closing price. On the day, 1022384 shares were traded.
Ratios:
We take a closer look at IGC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGC now has a Market Capitalization of 25.43M and an Enterprise Value of 24.43M. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.84 while its Price-to-Book (P/B) ratio in mrq is 2.81. Its current Enterprise Value per Revenue stands at 20.09 whereas that against EBITDA is -2.21.
Stock Price History:
Over the past 52 weeks, IGC has reached a high of $0.50, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.3132, while the 200-Day Moving Average is calculated to be 0.3239.
Shares Statistics:
According to the various share statistics, IGC traded on average about 470.13K shares per day over the past 3-months and 861.69k shares per day over the past 10 days. A total of 63.73M shares are outstanding, with a floating share count of 56.73M. Insiders hold about 10.98% of the company’s shares, while institutions hold 3.87% stake in the company. Shares short for IGC as of Feb 29, 2024 were 910.73k with a Short Ratio of 1.94, compared to 961.25k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.43% and a Short% of Float of 1.52%.
